Thoughts
Omniome
Very low-cost genomic and proteomic sequencing in silicon
First Investment: 2014
EXIT - Acquisition (Pacific Biosciences: PACB)
Omniome developed a proprietary DNA sequencing platform that delivered more accurate short reads than competing systems. Pacific Biosciences acquired the company in 2021.
News & Insights
Explore Companies
Latus Bio
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Noetik
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer